NS · Pharmaceuticals

Supriya Lifescience Ltd (SUPRIYA)

Pharmaceuticals & Biotechnology

Supriya Lifescience Ltd (SUPRIYA) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-03, reported market cap is $77.42B, P/E ratio is 37.02, net margin is 24.0%, dividend yield is 0.10%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for SUPRIYA

Market cap

$77.42B

P/E ratio

37.02

Net margin

24.0%

Dividend yield

0.10%

Supriya Lifescience Ltd (SUPRIYA) — FAQ

What is Supriya Lifescience Ltd's market cap?

Supriya Lifescience Ltd (SUPRIYA) has a reported market cap of $77.42B (data as of 2026-07-03).

What is SUPRIYA's P/E ratio?

The price-to-earnings (P/E) ratio for Supriya Lifescience Ltd (SUPRIYA) is 37.02 (data as of 2026-07-03).

Does Supriya Lifescience Ltd pay a dividend?

Supriya Lifescience Ltd (SUPRIYA) shows a reported dividend yield of 0.10%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-03).

What sector is Supriya Lifescience Ltd in?

Supriya Lifescience Ltd (SUPRIYA) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).

What exchange is SUPRIYA listed on?

SUPRIYA is listed on NS.

What is Supriya Lifescience Ltd's net margin?

Supriya Lifescience Ltd (SUPRIYA) reports a net margin of 24.0% (data as of 2026-07-03).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Pharmaceuticals companies

FDC Ltd (FDC) Strides Pharma Science Ltd (STAR)